The Pacific Pediatric Neuro-Oncology Consortium (PNOC) is a network of 15 of the nation’s leading hospitals with the common goal of better understanding pediatric brain tumor development, leading to personalized strategies and ultimately a cure of the devastating disease.
PNOC focuses on distinguishing the differences between every child’s brain tumor characteristics. As unique as a child’s personality, the pathology of a brain tumor is equally distinguishable. PNOC pursues clinical strategies based on the molecular and genetic make-up of each tumor and tests therapies to interfere with the specific cellular pathway, thus creating a personalized protocol, maximizing efficacy, and sparing children from therapy that is not optimized for their tumor type.
As the goal is to find a cure for aggressive cancer, through the clinical trials the team’s research findings are translated into therapies for physicians to treat these children most in need.
It is through this chain of learning and collaboration that PNOC pursues to find a cure for pediatric brain tumors.
To save as many lives as possible, as quickly as possible, PNOC has opted to not receive funding from national mechanisms but relies on the generous support of partner industry and friend sponsors.